Search results for "Protocol"

showing 10 items of 1808 documents

Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer

2007

Abstract Objective. Docetaxel and carboplatin are active in relapsed ovarian, peritoneal and tubal cancer. Recently, two prospective-randomized trials showed an advantage of carboplatin combination regimen with paclitaxel or gemcitabine over carboplatinum alone in platinum-sensitive cases. The question on the most effective combination with the best tolerable side effects still needs to be answered. Methods. Eligible patients had recurrent ovarian, peritoneal or tubal cancer (platinum-free interval >6 months), performance status 0–2 and normal bone marrow, renal and hepatic function. 25 patients (age 18–75 years) were enrolled into this phase II trial. Patients with debulking operation of r…

AdultOncologymedicine.medical_specialtyPopulationDocetaxelGastroenterologyDisease-Free SurvivalCarboplatinchemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineFallopian Tube NeoplasmsHumanseducationPeritoneal NeoplasmsAgedOvarian Neoplasmseducation.field_of_studyPerformance statusbusiness.industryObstetrics and GynecologyCancerMiddle AgedDebulkingmedicine.diseaseGemcitabineCarboplatinRegimenOncologyDocetaxelchemistryDrug Resistance NeoplasmFemaleTaxoidsNeoplasm Recurrence Localbusinessmedicine.drugGynecologic Oncology
researchProduct

Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied

1998

High-dose chemotherapy with autologous transplantation of in vivo purged PBSC is a novel investigational approach to treating chronic myelogenous leukemia (CML) patients not responsive to conventional therapy with interferon-alpha (IFN-alpha) and not eligible for allogeneic transplantation. PBSC mobilization using either '5+2/7+3'-type chemotherapy or 'mini-ICE/ ICE' chemotherapy was investigated in 43 patients with advanced phases of Philadelphia (Ph)-positive CML. Thirty patients were in late chronic phase (12 months post diagnosis) and 13 patients in accelerated phase (AP) or blast crisis (BC). Contamination with Ph-positive cells was evaluated in harvests from 37/43 patients. The outcom…

AdultOncologymedicine.medical_specialtyTime FactorsAllogeneic transplantationmedicine.medical_treatmentPilot ProjectsCarboplatinCohort StudiesLeukemia Myelogenous Chronic BCR-ABL PositiveInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAutologous transplantationIfosfamideEtoposideChemotherapyMobilizationHematologybusiness.industryHematologyGeneral MedicineLeukapheresisMiddle Agedmedicine.diseaseHematopoietic Stem Cell MobilizationSurgeryTreatment OutcomeBlast CrisisComplicationbusinessChronic myelogenous leukemiaAnnals of Hematology
researchProduct

Study protocol: fit for delivery - can a lifestyle intervention in pregnancy result in measurable health benefits for mothers and newborns? A randomi…

2013

Abstract Background The global obesity epidemic has led to increased attention on pregnancy, a period when women are at risk of gaining excessive weight. Excessive gestational weight gain is associated with numerous complications, for both mother and child. Though the problem is widespread, few studies have examined the effect of a lifestyle intervention in pregnancy designed to limit maternal weight gain. The Fit for Delivery study will explore the effectiveness of nutritional counseling coupled with exercise classes compared with standard prenatal care. The aims of the study are to examine the effect of the intervention on maternal weight gain, newborn birth weight, glucose regulation, co…

AdultPediatricsmedicine.medical_specialtyTime FactorsComplications of pregnancyHealth StatusBirth weightMothersPrenatal carelarge for gestational ageOverweightlaw.inventionStudy ProtocolRandomized controlled triallawSurveys and QuestionnairesOutcome Assessment Health CaremedicineHumansLife Styleweight retentionPregnancyexerciseNorwaybusiness.industrylcsh:Public aspects of medicineInfant NewbornPublic Health Environmental and Occupational Healthlcsh:RA1-1270Prenatal CareVDP::Medical disciplines: 700::Health sciences: 800Overweightmedicine.diseaseGestational diabetesnutritiongestational weight gainrandomized controlled trialFemalePregnant Womenpregnancymedicine.symptomgestational diabetesbusinessWeight gainFollow-Up StudiesBMC Public Health
researchProduct

Whole-body MRI radiomics model to predict relapsed/refractory Hodgkin Lymphoma: A preliminary study.

2022

Purpose A strong prognostic score that enables a stratification of newly diagnosed Hodgkin Lymphoma (HL) to identify patients at high risk of refractory/relapsed disease is still needed. Our aim was to investigate the potential value of a radiomics analysis pipeline from whole-body MRI (WB-MRI) exams for clinical outcome prediction in patients with Hodgkin Lymphoma (HL). Materials and methods Index lesions from baseline WB-MRIs of 40 patients (22 females; mean age 31.7 ± 11.4 years) with newly diagnosed HL treated by ABVD chemotherapy regimen were manually segmented on T1-weighted, STIR, and DWI images for texture analysis feature extraction. A machine learning approach based on the Extra T…

AdultPositron emission tomographymedicine.medical_specialtyWhole body mriBiomedical EngineeringBiophysicsVinblastineBleomycinYoung AdultRefractoryRadiomicsPositron Emission Tomography Computed TomographyMachine learningAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansRadiology Nuclear Medicine and imagingMagnetic resonance imaging Positron emission tomography Machine learning Texture analysis Hodgkin Lymphomamedicine.diagnostic_testHodgkin Lymphomabusiness.industryMagnetic resonance imagingMetabolic tumor volumeHodgkin DiseaseMagnetic Resonance ImagingDacarbazineTexture analysisPositron emission tomographyDoxorubicinRelapsed refractoryHodgkin lymphomaFemaleRadiologySettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessMagnetic resonance imaging
researchProduct

The randomized shortened dental arch study (RaSDA): design and protocol

2010

Abstract Background Various treatment options for the prosthetic treatment of jaws where all molars are lost are under discussion. Besides the placement of implants, two main treatment types can be distinguished: replacement of the missing molars with removable dental prostheses and non-replacement of the molars, i.e. preservation of the shortened dental arch. Evidence is lacking regarding the long-term outcome and the clinical performance of these approaches. High treatment costs and the long time required for the treatment impede respective clinical trials. Methods/design This 14-center randomized controlled investigator-initiated trial is ongoing. Last patient out will be in 2010. Patien…

AdultResearch designTime FactorsMedicine (miscellaneous)DentistryPilot ProjectsProsthesis Designlaw.inventionTooth LossDental ArchPatient satisfactionstomatognathic systemRandomized controlled trialQuality of lifelawGermanyStudy protocolTooth lossPremolarHumansMedicinePharmacology (medical)Orthodonticslcsh:R5-920business.industryJaw Edentulous PartiallyClinical trialDental ImplantationDental archTreatment Outcomemedicine.anatomical_structurePatient SatisfactionResearch DesignQuality of LifeDenture Partial FixedDenture Partial Removablemedicine.symptomlcsh:Medicine (General)businessTrials
researchProduct

Long-term outcome of treatment with dacarbazine, cisplatin, interferon-α and intravenous high dose interleukin-2 in poor risk melanoma patients

1998

Melanoma patients with very advanced disease are usually excluded from chemoimmunotherapy trials; however, the efficacy of intensive treatment regimens needs to be established for this patient population. This study aimed to evaluate the response rate and survival achieved with chemoimmunotherapy in very advanced melanoma patients. Forty-two patients received dacarbazine (250 mg/m2, days 1-3), cisplatin (30mg/m2, days 1-3), interferon-alpha (10 Mio IU/m2 subcutaneously, days 1-5) and intravenous interleukin-2 (18 Mio IU/m2 over 6 h, 12 h then 24 h, followed by 13.5 MioIU/m2 in 72 h). In cases of brain metastases (n = 12) radiation therapy was added. Ten patients (24%) achieved a partial res…

AdultRiskInterleukin 2Cancer Researchmedicine.medical_specialtySkin NeoplasmsTime Factorsmedicine.medical_treatmentDacarbazineDermatologyGastroenterologyStable DiseaseChemoimmunotherapyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasm MetastasisMelanomaAgedResponse rate (survey)CisplatinL-Lactate DehydrogenaseBrain Neoplasmsbusiness.industryMelanomaInterferon-alphaMiddle AgedPrognosismedicine.diseaseDacarbazineSurvival RateRadiation therapyTreatment OutcomeOncologyInterleukin-2Cisplatinbusinessmedicine.drugMelanoma Research
researchProduct

Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transp…

1999

We have determined the effect of delayed addition of G-CSF after chemotherapy on PBPC mobilization in a group of 30 patients with high risk breast cancer (HRBC) undergoing standard chemotherapy followed by high-dose chemotherapy (HDCT) and autologous SCT. Patients received FAC chemotherapy every 21 days followed by G-CSF at doses of 5 microg/kg/day starting on day +15 (groups 1 and 2) or +8 (group 3) after chemotherapy. PBPC collections were performed daily starting after 4 doses of G-CSF and continued until more than 2.5 x 10(6) CD34+ cells had been collected. In group 1, steady-state BM progenitors were also harvested and used for SCT. Groups 2 and 3 received PBPC only. The median number …

AdultRiskmedicine.medical_specialtyAdolescentPlatelet Engraftmentmedicine.medical_treatmentCD34UrologyBreast NeoplasmsTransplantation AutologousBreast cancerAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorHumansMedicineProgenitor cellTransplantationChemotherapybusiness.industryHematopoietic Stem Cell TransplantationHematologyMiddle Agedmedicine.diseaseHematopoietic Stem Cell MobilizationSurgeryGranulocyte colony-stimulating factorTransplantationFemaleStem cellbusinessBone Marrow Transplantation
researchProduct

A study protocol for applying the co-creating knowledge translation framework to a population health study

2013

Background: Population health research can generate significant outcomes for communities, while Knowledge Translation (KT) aims to expressly maximize the outcomes of knowledge producing activity. Yet the two approaches are seldom explicitly combined as part of the research process. A population health study in Port Lincoln, South Australia offered the opportunity to develop and apply the co-KT Framework to the entire research process. This is a new framework to facilitate knowledge formation collaboratively between researchers and communities throughout a research to intervention implementation process. Design: This study employs a five step framework (the co-KT Framework) that is formulate…

AdultRural PopulationKnowledge managementAdolescentParticipatory action researchHealth InformaticsKnowledge frameworkKnowledge creationKnowledge translationTranslational Research BiomedicalStudy ProtocolYoung Adult03 medical and health sciences0302 clinical medicineNursingKnowledge translationSouth AustraliaHumansMedicine030212 general & internal medicineAction researchChildHealth policyAgedMedicine(all)business.industry030503 health policy & servicesHealth PolicyPopulation healthPublic Health Environmental and Occupational HealthHealth services researchInfantGeneral MedicineMiddle AgedKnowledge baseResearch DesignChild PreschoolPopulation SurveillanceCommunity healthKnowledge translation modelCommunity health0305 other medical sciencebusinessAction researchEngaged scholarshipImplementation Science
researchProduct

A study of factors that may influence the determination of copper, iron, and zinc in human milk during sampling and in sample individuals.

1999

The aim of this study was to establish the possible effects of the sampling protocol (between-breast, within-feed, and diurnal differences) and the mother's personal factors (age, parity, iron supplementation, smoking habits, and lactation period) on the copper, iron, and zinc contents in human milk. One hundred thirty-six human milk samples identified by their origin and sampling conditions were analyzed. The samples were obtained from the 2nd to 15th d postpartum from 62 women. The data on the individuals required for the study were available. Mineral determinations were analyzed by flame atomic absorption spectrometry following a standardized protocol. The results showed that iron conten…

AdultSampling protocolEndocrinology Diabetes and MetabolismSample (material)IronClinical Biochemistrychemistry.chemical_elementZincBiochemistryInorganic ChemistryAnimal scienceLactationmedicineHumansBreastMilk HumanChemistryBiochemistry (medical)SmokingSampling (statistics)General MedicineCopperCircadian RhythmZincmedicine.anatomical_structureEnvironmental chemistryDietary SupplementsColostrumFemaleParity (mathematics)CopperBiological trace element research
researchProduct

Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy?

2015

To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the first surgical assessment was performed.Retrospective analysis of primary AEOC patients was performed and three groups were formed based on where the decision of primary treatment was taken: Internal, if the decision was carried out at our Institution (PDS (Primary Debulking Surgery), I-IDS (Internal-Interval Debulking Surgery)) and Referred in case women were referred after neoadjuvant chemotherapy (NACT) from other Centers (R-IDS (Referred-Interval Debulking Surgery)).Among 573 AEOC, 279 (48.7%) were PDS and 294 (51.3%) IDS. In particular, 134 of 294 (45.6%) were R-IDS and 160 (54.4%) were I-IDS.…

AdultTertiary Care CenterCarcinoma Ovarian EpithelialDisease-Free SurvivalcytoreductionTertiary Care CentersOvarian cancerAntineoplastic Combined Chemotherapy ProtocolsHumansNeoplasms Glandular and EpithelialAgedNeoplasm StagingAged 80 and overOvarian NeoplasmsCytoreduction; Interval debulking surgery; Ovarian cancer; PrognosisClinical Trials as TopicAntineoplastic Combined Chemotherapy ProtocolOvarian NeoplasmMiddle AgedPrognosisNeoadjuvant TherapySettore MED/40 - GINECOLOGIA E OSTETRICIAinterval debulking surgeryFemaleprognosineoadjuvant chemotherapyHuman
researchProduct